Holen Sie sich die Stockscreener-App
10.50
0.28%
-0.03
Handel nachbörslich:
10.50
Daxor Corporation Aktie (DXR) Neueste Nachrichten
Daxor to exhibit blood volume analyzer at dysautonomia conference By Investing.com - Investing.com Canada
Daxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, Texas - The Manila Times
Daxor debuts Blood Volume Analyzer at dysautonomia conference - Stock Titan
DXRDaxor Corp Options - Finviz
Avoiding Lag: Real-Time Signals in (DXR) Movement - Stock Traders Daily
Daxor Corporation (DXR) Edges Higher, Testing Key Resistance ZoneAdvance Decline Volume - dars.gov.et
Enterprise value to EBITDA forward of Daxor Corporation – NASDAQ:DXR - TradingView
Price to sales forward of Daxor Corporation – FWB:DX5 - TradingView
Price to book forward of Daxor Corporation – FWB:DX5 - TradingView
Enterprise value to revenue forward of Daxor Corporation – NASDAQ:DXR - TradingView
Enterprise value to EBIT forward of Daxor Corporation – NASDAQ:DXR - TradingView
Price to earnings forward of Daxor Corporation – NASDAQ:DXR - TradingView
Enterprise value to EBITDA forward of Daxor Corporation – FWB:DX5 - TradingView
Daxor Corporation (DXR) Edges Lower, Testing Support Levels Near $10.25Market Profile - dars.gov.et
DX5 Forecast — Price Target — Prediction for 2027 - TradingView
Daxor Corporation Actuals & Estimates (NASDAQ:DXR) - TradingView
DXR Forecast — Price Target — Prediction for 2027 - TradingView
Form 4 Daxor Corp For: 25 June By Investing.com - Investing.com South Africa
Daxor (DXR) CFO receives 12,000-share stock grant, now holds 33,050 - Stock Titan
DAXOR (DXR) CEO receives 30,000-share equity grant, now holds 243,694 - Stock Titan
Daxor (DXR) Chief Scientific Officer receives 25,000-share stock grant - Stock Titan
Daxor (DXR) director granted 2,500 stock options at $10.14 - Stock Titan
Daxor (DXR) director awarded 2,500 stock options at $10.14 strike - Stock Titan
DAXOR CORP (DXR) director receives 2,500 stock options at $10.14 strike - Stock Titan
DAXOR (DXR) director awarded 2,500 stock options at $10.14 strike price - Stock Titan
Daxor Shareholders Reelect Board and Ratify Auditor - The Globe and Mail
Daxor Corporation 8-K Filing June 2026: Shareholder Vote Results, Nasdaq Listing, and Company Details - Minichart
Daxor (NASDAQ: DXR) investors reelect full board and ratify Bush & Associates as auditor - Stock Titan
Number of shareholders of Daxor Corporation – BOATS:DXR - TradingView
Daxor Corporation (DXR) Holds Near Support After Modest DeclineAdaptive Moving Average - dars.gov.et
Discipline and Rules-Based Execution in DXR Response - Stock Traders Daily
Daxor (DXR) Proxy Filing Summary - Quartr
Daxor (DXR) Q4 2025 earnings summary - Quartr
Daxor (DXR) Q2 2024 earnings summary - Quartr
Daxor (DXR) Corporate Presentation Summary - Quartr
Daxor (DXR) Q4 2024 earnings summary - Quartr
Daxor Corp (DXR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Daxor Corp (DXR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Daxor Corp (DXR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Daxor Corp (DXR) Institutional Confidence - TradingKey
Daxor Corp (DXR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Daxor Corp (DXR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Daxor Corp (DXR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Daxor Corp (DXR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Daxor Corp (DXR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Behavioral Patterns of DXR and Institutional Flows - Stock Traders Daily
Daxor Corporation (DXR) Declines 4.39%: Approaching Key Support Near $10.07PCR Moving Average - newsline.com
Daxor Corporation (DXR) Q3 2007 Earnings: EPS Surges 325% Above Estimates, Stock Declines Despite Beat - newsline.com
Daxor (DXR) plans June 23, 2026 vote on directors and auditor - Stock Titan
Daxor (DXR) Proxy filing Summary - Quartr
Daxor (DXR) Secures Patent for Innovative Blood Volume Monitorin - GuruFocus
Daxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume Monitor - GlobeNewswire
Daxor Corporation (DXR) Surges 4.1%: Testing Resistance After Strong Intraday MomentumHagopian Line - newsline.com
(DXR) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
DXR Q3 2007 Earnings: Earnings Per Share Surges Past EstimatesFiscal Year Earnings - dars.gov.et
Daxor Corporation (DXR) Holds Steady at $10.82 as Shares Test Key Support ZoneOpen Trading Community - Newser
DXR Q3 2007 Earnings: Significant Earnings Beat Driven by Strong Operational PerformanceEarnings Sentiment Score - Newser
Daxor Corporation (DXR) Q3 2007 Earnings: Landmark EPS Beat Lifts Sentiment Despite No Revenue DisclosureSocial Signal Watchlist - Newser
1.24%
2.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):